Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier

Molecules

Volumn 18, Issue 9, 2013, Pages 11537-11552

  Hemmer, Ruth ^a   Hall, Andrew ^a   Spaulding, Robert ^a   Rossow, Brett ^a   Hester, Michael ^a   Caroway, Megan ^a   Haskamp, Anthony ^a   Wall, Steven ^a   Bullen, Heather A ^a   Morris, Celeste ^a   Haik, Kristi L ^a  

^a NORTHERN KENTUCKY UNIVERSITY   (United States)

Author keywords

Atomic force microscopy; Biotin; Dendrimers; Fluorescence microscopy; Toxicity

Indexed keywords

DENDRIMER; DRUG CARRIER; PAMAM STARBURST;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOTINYLATION; BLOOD BRAIN BARRIER; BRAIN; CELL CULTURE; COCULTURE; DRUG SCREENING; METABOLISM; RAT; TISSUE DISTRIBUTION;

ANIMALS; BIOTINYLATION; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRIMERS; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; MODELS, BIOLOGICAL; RATS; TISSUE DISTRIBUTION;

EID: 84885131154     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules180911537     Document Type: Article

References (77)

1. Zhang, L.; Zhu, S.; Qian, L.; Pei, Y.; Qiu, Y.; Jiang, Y. Rgd-modified PEG-PAMAM-DOX conjugates: In vitro and in vivo studies for glioma. Eur. J. Pharm. Biopharm. 2011, 79, 232-240.
2. Montero, A.J.; Adams, B.; Diaz-Montero, C.M.; Gluck, S. Nab-paclitaxel in the treatment of metastatic breast cancer: A comprehensive review. Expert Rev. Clin. Pharmacol. 2011, 4, 329-334.
3. Lim, Z.Z.; Li, J.E.; Ng, C.T.; Yung, L.Y.; Bay, B.H. Gold nanoparticles in cancer therapy. Acta Pharmacol. Sin. 2011, 32, 983-990. blood brain barrier; lactate dehydrogenase assay
4. Deeken, J.F.; Löscher, W. The blood-brain barrier and cancer: Transporters, treatment, and trojan horses. Clin. Cancer. Res. 2007, 13, 1663-1674. (Pubitemid 46952931)
5. Koziara, J.M.; Whisman, T.R.; Tseng, M.T.; Mumper, R.J. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J. Control. Release 2006, 112, 312-319. (Pubitemid 43737150)
6. Yang, C.-S.; Chang, C.-H.; Tsai, P.-J.; Chen, W.-Y.; Tseng, F.-G.; Lo, L.-W. Nanoparticle-based in vivo investigation on blood-brain barrier permeability following ischemia and reperfusion. Anal. Chem. 2004, 76, 4465-4471. (Pubitemid 39014022)
7. Dermietzel, R.; Krause, D. Molecular anatomy of the blood-brain barrier as defined by immunocytochemistry. Int. Rev. Cytol. 1991, 127, 57-109.
8. Reese, T.S.; Karnovsky, M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967, 34, 207-217.
9. Savettieri, G.; Di Liegro, I.; Catania, C.; Licata, L.; Pitarresi, G.L.; D'Agostino, S.; Schiera, G.; de Caro, V.; Giandalia, G.; Giannola, L.I.; et al. Neurons and ecm regulate occludin localization in brain endothelial cells. Neuroreport 2000, 11, 1081-1084. (Pubitemid 30235459)
10. Yang, H. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm. Res. 2010, 27, 1759-1771.
11. Bhaskar, S.; Tian, F.; Stoeger, T.; Kreyling, W.; de la Fuente, J.; Grazú, V.; Borm, P.; Estrada, G.; Ntziachristos, V.; Razansky, D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: Perspectives on tracking and neuroimaging. Part Fibre Toxicol. 2010, 7, 1-25.
12. Agarwal, A.; Lariya, N.; Saraogi, G.; Dubey, N.; Agrawal, H.; Agrawal, G.P. Nanoparticles as novel carrier for brain delivery: A review. Curr. Pharm. Des. 2009, 15, 917-925.
13. Gilmore, J.L.; Xiang, Y.; Lingdong, Q.; Kabanov, A. Novel nanomaterials for clinical neuroscience. J. Neuroimmune Pharmacol. 2008, 3, 83-94.
14. Dykes, G.M. Dendrimers: A review of their appeal and applications. J. Chem. Technol. Biotechnol. 2001, 76, 903-918. (Pubitemid 32825595)
15. Tomalia, D.A. Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Prog. Polym. Sci. 2005, 30, 294-324. (Pubitemid 40642933)
16. Tomalia, D.A. The emergence of a new macromolecular architecture: The dendritic state. In Physical Properties of Polymers Handbook; Mark, J.E., Ed. Springer: New York, NY, USA, 2007; pp. 671-692.
17. Tomalia, D.A.; Henderson, S.A.; Diallo, M.S. Dendrimers - an enabling synthetic science to controlled organic nanostructures. In Handbook of Nanoscience, Engineering and Technology; Goddard, W.A.I., Brenner, D.W., Lyshevski, S.E., Irafrate, G.J., Eds. CRC Press: Taylor and Francis: Boca Raton, FL, USA, 2007; pp. 24.21-24.47.
18. Astruc, D.; Boisselier, E.; Ornelas, C. Dendrimers designed for functions: From physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. Chem. Rev. 2010, 110, 1857-1959.
19. Gajbhiye, V.; Palanirajan, V.K.; Tekade, R.K.; Jain, N.K. Dendrimers as therapeutic agents: A systematic review. J. Pharm. Pharmacol. 2010, 61, 989-1003.
20. Mintzer, M.A.; Grinstaff, M.W. Biomedical applications of dendrimers: A tutorial. Chem. Soc. Rev. 2011, 40, 173-190.
21. Wijagkanalan, W.; Kawakami, S.; Hashida, M. Designing dendrimers for drug delivery and imaging: Pharmacokinetic considerations. Pharm. Res. 2011, 28, 1500-1519.
22. Boas, U.; Heegaard, P.M. Dendrimers in drug research. Chem. Soc. Rev. 2004, 33, 43-63. (Pubitemid 38376610)
23. Petkar, K.C.; Chavhan, S.S.; Agatonovik-Kustrin, S.; Sawant, K.K. Nanostructured materials in drug and gene delivery: A review of the state of the art. Crit. Reve. Therm. Drug Carrier Syst. 2011, 28, 101-164.
24. Huang, R.; Ke, W.; Han, L.; Liu, Y.; Shao, K.; Ye, L.; Lou, J.; Jiang, C.; Pei, Y. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles. J. Cereb Blood Flow Metab 2009, 29, 1914-1923.
25. Wu, G.; Barth, R.F.; Yang, W.; Kawabata, S.; Zhang, L.; Green-Church, K. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225 dendrimer bioconjugates. Mol. Cancer Ther. 2006, 5, 52-59.
26. Kaneshiro, T.L.; Lu, Z.R. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 2009, 30, 5660-5666.
27. Spector, R.; Mock, D. Biotin transport through the blood-brain barrier. J. Neurochem. 1987, 48, 400-404. (Pubitemid 17005146)
28. Shi, F.; Bailey, C.; Malick, A.W.; Audus, K.L. Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers. Pharm. Res. 1993, 10, 282-288. (Pubitemid 23041745)
29. Beg, S.; Samad, A.; Alam, M.I.; Nazish, I. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS Neurol. Disord. Drug Targets 2011, 10, 576-588.
30. Bullen, H.A.; Hemmer, R.; Haskamp, A.; Cason, C.A.; Wall, S.; Spaulding, R.; Rossow, B.; Hester, M.; Caroway, M.; Haik, K.L. Evaluation of biotinylated pamam dendrimer toxicity in models of the blood brain barrier: A biophysical and cellular approach. J. Biomater. Nanobiotechnol. 2011, 2, 485-493.
31. Sato, N.; Kobayashi, H.; Saga, T.; Nakamoto, Y.; Ishimori, T.; Togashi, K.; Fujibayashi, Y.; Konishi, J.; Brechbiel, M.W. Tumor targeting and imaging of interaperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin. Cancer. Res. 2001, 7, 3606-3612. (Pubitemid 33070001)
32. Wilbur, D.S.; Pathare, P.M.; Hamlin, D.K.; Buhler, K.R.; Vessella, R.L. Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconjug. Chem. 1998, 9, 813-825. (Pubitemid 28542250)
33. Yoon, H.C.; Hong, M.Y.; Kim, H.S. Affinity biosensor for avidin using a double functionalized dendrimer monolayer on a gold electrode. Anal. Biochem. 2000, 282, 121-128. (Pubitemid 30409433)
34. Pericet-Camara, R.; Papastavrou, G.; Borkovec, M. Atomic force microscopy study of the adsorption and electrostatic self-organization of poly(amidoamine) dendrimers on mica. Langmuir 2004, 20, 3264-3270.
35. Zhang, H.; Grim, P.C.M.; Foubert, P.; Vosch, T.; Vanoppen, P.; Wiesler, U.M.; Berresheim, A.J.; Müllen, K.; de Schryver, F.C. Properties of single dendrimer molecules studied by atomic force microscopy. Langmuir 2000, 16, 9009-9014. (Pubitemid 32022833)
36. Melling, M.; Hochmeister, S.; Blumer, R.; Schilcher, K.; Mostler, S.; Behnam, M.; Wilde, J.; Karimian-Teherani, D. Atomic force microscopy imaging of the human trigeminal ganglion. Neuroimage 2001, 14, 1348-1352. (Pubitemid 33124182)
37. Nie, H.-Y.; Taylor, A.R.; Lau, W.M.; MacFabe, D.F. Subcellular features revealed on unfixed rat brain sections by phase imaging. Analyst 2011, 136, 2270-2276.
38. Li, J.; Piehler, L.T.; Qin, D.; Baker, J.R.; Tomalia, D.A.; Meier, D.J. Visualization and characterization of poly(amidoamine) dendrimers by atomic force microscopy. Langmuir 2000, 16, 5613-5616.
39. Thalhammer, A.; Edgington, R.J.; Cingolani, L.A.; Schoepfer, R.; Jackman, R.B. The use of nanodiamond monolayer coatings to promote the formation of functional neuronal networks. Biomaterials 2010, 31, 2097-2014.
40. Serem, W.K.; Bett, C.K.; Ngujiri, J.N.; Garno, J.C. Studies of the growth, evolution, and self-aggregation of β-amyloid fibrils using tapping-mode atomic force microscopy. Microsc. Res. Tech. 2011, 74, 699-708.
41. Harper, J.D.; Lieber, C.M.; Lansbury Jr, P.T. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the alzheimer's disease amyloid-β protein. Chem. Biol. 1997, 4, 951-959. (Pubitemid 28050379)
42. Kowalewski, T.; Holtzman, D.M. In situ atomic force microscopy study of alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation. Proc. Natl. Acad. Sci. USA 1999, 96, 3688-3693. (Pubitemid 29168971)
43. Jiang, W.; Duysen, E.G.; Hansen, H.; Shlyakhtenko, L.; Schopfe, L.M.; Lockridge, O. Mice treated with chlorpyrifos or chlorpyrifos oxon have organophosphorylated tubulin in the brain and disrupted microtubule structures, suggesting a role for tubulin in neurotoxicity associated with exposure to organophosphorus agents. Toxicol. Sci. 2010, 115, 183-193.
44. Christ, A.F.; Franze, K.; Gautier, H.; Moshayedi, P.; Fawcett, J.; Franklin, R.J.; Karadottir, R.T.; Guck, J. Mechanical difference between white and gray matter in the rat cerebellum measured by scanning force microscopy. J. Biomech. 2010, 43, 2986-2992.
45. Ciolkowski, M.; Rozanek, M.; Szewczyk, M.; Klajnert, B.; Bryszewska, M. The influence of PAMAM-OH dendrimers on the activity of human erythrocytes atpases. Biochim. Biophys. Acta 2011, 1808, 2714-2723.
46. Jevprasesphant, R.; Penny, J.; Jalal, R.; Attwood, D.; McKeown, N.B.; D'Emanuele, A. The influence of surface modification on the cytotoxicity of pamam dendrimers. Int. J. Pharm. 2003, 252, 263-266. (Pubitemid 36126635)
47. Wang, W.; Xiong, W.; Zhu, Y.; Xu, H.; Yang, X. Protective effect of pegylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 93, 59-64.
48. Spector, R.; Mock, D.M. Biotin transport and metabolism in the central nervous system. Neurochem. Res. 1988, 13, 213-219.
49. De Boer, A.G.; Gaillard, P.J. In vitro models of the blood-brain barrier: When to use which? Curr. Med. Chem. Cent. Nerv. Syst. Agents 2002, 2, 203-209. (Pubitemid 36267725)
50. Garberg, P.; Ball, M.; Borg, N.; Cecchelli, R.; Fenart, L.; Hurst, R.D.; Lindmark, T.; Mabondzo, A.; Nilsson, J.E.; Raub, T.J.; et al. In vitro models for the blood-brain barrier. Toxicol. In Vitro 2005, 19, 299-334. (Pubitemid 40248750)
51. Avalos Funez, A.; Isabel Haza, A.; Mateo, D.; Morales, P. In vitro evaluation of silver nanoparticles on human tumoral and normal cells. Toxicol. Mech. Methods 2013, 23, 153-160.
52. Weiss, V.M.; Naolou, T.; Groth, T.; Kressler, J.; Mader, K. In vitro toxicity of stearoylpoly (glycerol adipate) nanoparticles. J. Appl. Biomater. Funct. Mater. 2012, 10, 163-169.
53. Gelperina, S.; Maksimenko, O.; Khalansky, A.; Vanchugova, L.; Shipulo, E.; Abbasova, K.; Berdiev, R.; Wohlfart, S.; Chepurnova, N.; Kreuter, J. Drug delivery to the brain using surfactantcoated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters. Eur. J. Pharm. Biopharm. 2010, 74, 157-163.
54. Weiss, C.; Kohnle, M.; Landfester, K.; Hauk, T.; Fischer, D.; Schmitz-Wienke, J.; Mailander, V. The first step into the brain: Uptake of NiO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation. ChemMedChem 2008, 3, 1395-1403.
55. Wang, D.; Imae, T. Fluorescence emission from dendrimers and its pH dependence. J. Am. Chem. Soc. 2004, 126, 13204-13205. (Pubitemid 39382730)
56. Perumal, O.P.; Inapagolla, R.; Kannan, S.; Kannan, R.M. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 2008, 29, 3469-3476.
57. Duran-Vilaregut, J.; del Valle, J.; Camins, A.; Pallas, M.; Pelegri, C.; Vilaplana, J. Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid. Neurotoxicology 2009, 30, 136-143.
58. Duran-Vilaregut, J.; Manich, G.; del Valle, J.; Pallas, M.; Camins, A.; Pelegri, C.; Vilaplana, J. Neuronal apoptosis in the striatum of rats treated with 3-nitropropionic acid is not triggered by cell-cycle re-entry. Neurotoxicology 2011, 32, 734-741.
59. Prieto, M.J.; Schilrreff, P.; Tesoriero, M.V.; Morilla, M.J.; Romero, E.L. Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine. Int. J. Pharm. 2008, 360, 204-212.
60. Dai, H.; Navath, R.S.; Balakrishnan, B.; Guru, B.R.; Mishra, M.K.; Romero, R.; Kannan, R.M.; Kannan, S. Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine (Lond) 2010, 5, 1317-1329.
61. Zhang, Y.; Sun, Y.; Xu, X.; Zhang, X.; Zhu, H.; Huang, L.; Qi, Y.; Shen, Y.M. Synthesis, biodistribution, and microsingle photon emission computed tomography (spect) imaging study of technetium-99m labeled pegylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates. J. Med. Chem. 2010, 53, 3262-3272.
62. Janaszewska, A.; Ziemba, B.; Ciepluch, K.; Appelhans, D.; Voit, B.; Klajnert, B.; Bryszewska, M. The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrier. New J. Chem. 2012, 36, 350-353.
63. Bhagavan, H.N.; Coursin, D.B. Depletion of biotin from brain and liver in biotin deficiency. J. Neurochem. 1970, 17, 289-290.
64. Wang, H.; Pevsner, J. Detection of endogenous biotin in various tissues: Novel functions in the hippocampus and implications for its use in avidin-biotin technology. Cell Tissue Res. 1999, 296, 511-516. (Pubitemid 29253681)
65. Wood, G.S.; Warnke, R. Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J. Histochem. Cytochem. 1981, 29, 1196-1204. (Pubitemid 11061054)
66. McKay, B.E.; Molineux, M.L.; Turner, R.W. Endogenous biotin in rat brain: Implications for false-positive results with avidin-biotin and streptavidin-biotin techniques. Methods Mol. Biol. 2008, 418, 111-128. (Pubitemid 351366015)
67. McKay, B.E.; Molineux, M.L.; Turner, R.W. Biotin is endogenously expressed in select regions of the rat central nervous system. J. Comp. Neurol. 2004, 473, 86-96. (Pubitemid 38507121)
68. Cason, C.A.; Fabre, T.A.; Buhrlage, A.; Haik, K.L.; Bullen, H.A. Low-level detection of poly(amidoamine) PAMAM dendrimers using immunoimaging scanning probe microscopy. Int. J. Anal. Chem. 2012, 2012, 341260.
69. Svenson, S.; Tomalia, D.A. Dendrimers in biomedical applications - Reflections on the field. Adv. Drug Deliv. Rev. 2005, 57, 2106-2129. (Pubitemid 41759389)
70. Hansma, H.G.; Hoh, J.H. Biomolecular imaging with the atomic force microscope. Annu. Rev. Biophys. Biomol. Struct. 1994, 23, 115-139. (Pubitemid 24217364)
71. Cason, C.A.; Oehrle, S.A.; Fabre, T.A.; Girten, C.; Walters, K.A.; Tomalia, D.A.; Haik, K.L.; Bullen, H.A. Improved methodology for monitoring poly(amidoamine) dendrimers surface transformations and product quality by ultra performance liquid chromatography. J. Nanomater. 2008, 2008, 456082.
72. Garcia-Garcia, E.; Gil, S.; Andrieux, K.; Desmaele, D.; Nicolas, V.; Taran, F.; Georgin, D.; Andreux, J.P.; Roux, F.; Couvreur, P. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. Cell Mol. Life Sci. 2005, 62, 1400-1408. (Pubitemid 40853828)
73. Szabo, C.A.; Deli, M.A.; Ngo, T.K.; Joo, F. Production of pure primary rat cerebral endothelial cell culture: A comparison of different methods. Neurobiology (Bp.) 1997, 5, 1-16. (Pubitemid 29111516)
74. Bonfoco, E.; Krainc, D.; Ankarcrona, M.; Nicotera, P.; Lipton, S.A. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with n- methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 1995, 92, 7162-7166.
75. Decker, T.; Lohmann-Matthes, M.-L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 1998, 15, 61-69.
76. Legrand, C.; Bour, J.; Jacob, C.; Capiaumont, J.; Martial, A.; Marc, A.; Wudtke, M.; Kretzmer, G.; Demangel, C.; Duval, D. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium J. Biotechnol. 1995, 25, 231-243.
77. Paxinos, G.; Watson, C. The Rat Brain in Sterotaxic Coordinates; Academic Press: San Diego, CA, USA, 1998.